Published in Mov Disord on April 12, 2011
Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology (2013) 2.35
Imaging nigral pathology and clinical progression in Parkinson's disease. Mov Disord (2012) 1.27
Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin (2013) 1.23
The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T. PLoS One (2014) 1.16
Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies. Neuroradiology (2013) 1.00
Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology. Biol Psychiatry (2012) 0.90
A multicontrast approach for comprehensive imaging of substantia nigra. Neuroimage (2015) 0.84
Neuromelanin-sensitive magnetic resonance imaging: a promising technique for depicting tissue characteristics containing neuromelanin. Neural Regen Res (2014) 0.79
Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia. PLoS One (2014) 0.78
Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI. MAGMA (2016) 0.77
Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density. PLoS One (2016) 0.77
Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism. Neuroradiology (2016) 0.77
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease. Front Aging Neurosci (2016) 0.76
A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging. Korean J Radiol (2016) 0.76
Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis. BMC Neurol (2012) 0.76
In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease. Hum Brain Mapp (2017) 0.76
Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update. Parkinsons Dis (2016) 0.75
Magnetic resonance imaging for the diagnosis of Parkinson's disease. J Neural Transm (Vienna) (2017) 0.75
Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease. J Neural Transm (Vienna) (2017) 0.75
Pool size ratio of the substantia nigra in Parkinson's disease derived from two different quantitative magnetization transfer approaches. Neuroradiology (2017) 0.75
Carotid intraplaque hemorrhage detected by magnetic resonance imaging predicts embolization during carotid endarterectomy. J Vasc Surg (2007) 2.64
Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation (2003) 2.43
Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology (2013) 2.35
Leukoaraiosis predicts the need for intraoperative shunt placement during carotid endarterectomy. Perspect Vasc Surg Endovasc Ther (2009) 2.12
Carotid intraplaque hemorrhage predicts recurrent symptoms in patients with high-grade carotid stenosis. Stroke (2007) 2.02
Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J Vasc Surg (2008) 1.89
Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med (2002) 1.76
'Importance sampling' in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment. J Neurol Sci (2005) 1.65
Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study. J Neurol Neurosurg Psychiatry (2012) 1.65
Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation (2003) 1.58
Brain structures mediating cardiovascular arousal and interoceptive awareness. Brain Res (2007) 1.58
Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord (2010) 1.56
A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol (2009) 1.46
Transcriptional data: a new gateway to drug repositioning? Drug Discov Today (2012) 1.40
Volitional reduction of anterior cingulate cortex activity produces decreased cue craving in smoking cessation: a preliminary real-time fMRI study. Addict Biol (2012) 1.36
High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J Magn Reson Imaging (2011) 1.35
Extrahippocampal gray matter loss and hippocampal deafferentation in patients with temporal lobe epilepsy. Epilepsia (2010) 1.33
Quantitative imaging biomarkers in neuro-oncology. Nat Rev Clin Oncol (2009) 1.28
Altered processing of acoustic stimuli during sleep: reduced auditory activation and visual deactivation detected by a combined fMRI/EEG study. Neuroimage (2002) 1.26
Carotid plaque hemorrhage on magnetic resonance imaging strongly predicts recurrent ischemia and stroke. Ann Neurol (2013) 1.24
Impaired speech repetition and left parietal lobe damage. J Neurosci (2010) 1.24
Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin (2013) 1.23
In vivo mapping of the human locus coeruleus. Neuroimage (2009) 1.21
Mapping anterior temporal lobe language areas with fMRI: a multicenter normative study. Neuroimage (2010) 1.21
Parietal updating of limb posture: an event-related fMRI study. Neuropsychologia (2006) 1.18
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol (2006) 1.17
A regularized two-tensor model fit to low angular resolution diffusion images using basis directions. J Magn Reson Imaging (2008) 1.15
MR tagging of human lungs using hyperpolarized 3He gas. J Magn Reson Imaging (2003) 1.13
Intermittent "real-time" fMRI feedback is superior to continuous presentation for a motor imagery task: a pilot study. J Neuroimaging (2010) 1.12
Functional MRI during sleep: BOLD signal decreases and their electrophysiological correlates. Eur J Neurosci (2004) 1.12
Compensatory neural reorganization in Tourette syndrome. Curr Biol (2011) 1.11
Interoceptive awareness, anxiety and cardiovascular reactivity to isometric exercise. Int J Psychophysiol (2007) 1.10
Functional microstates within human REM sleep: first evidence from fMRI of a thalamocortical network specific for phasic REM periods. Eur J Neurosci (2007) 1.10
Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett (2005) 1.09
Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry (2010) 1.08
Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7T MRI. Neurology (2014) 1.07
Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging (2011) 1.07
MR imaging of the substantia nigra for the diagnosis of Parkinson disease. Radiology (2014) 1.07
The medial frontal-prefrontal network for altered awareness and control of action in corticobasal syndrome. Brain (2013) 1.06
Carotid plaque hemorrhage on magnetic resonance imaging and recurrent cerebrovascular events. J Am Coll Cardiol (2014) 1.06
Measuring the hemodynamic response in chronic hypoperfusion. Neurocase (2006) 1.05
3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions. J Magn Reson Imaging (2010) 1.03
Covert orienting of attention and overt eye movements activate identical brain regions. Brain Res (2008) 1.03
Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry (2009) 1.01
The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat. Psychopharmacology (Berl) (2010) 1.01
Anxiety and hippocampus volume in the rat. Neuropsychopharmacology (2006) 1.00
Motor threshold in transcranial magnetic stimulation: the impact of white matter fiber orientation and skull-to-cortex distance. Hum Brain Mapp (2009) 1.00
Measurement of cervical spinal cord cross-sectional area by MRI using edge detection and partial volume correction. J Magn Reson Imaging (2005) 0.99
Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging. Neuropsychopharmacology (2007) 0.99
Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression. Neuroimage (2010) 0.98
Brain tractography using Q-ball imaging and graph theory: Improved connectivities through fibre crossings via a model-based approach. Neuroimage (2009) 0.98
Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome. Mult Scler (2012) 0.98
Is the brain cortex a fractal? Neuroimage (2003) 0.98
Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain. JAMA Neurol (2013) 0.98
Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis--a quantitative T1 relaxation time mapping approach. J Neurol (2003) 0.98
Spatial attention evokes similar activation patterns for visual and auditory stimuli. J Cogn Neurosci (2010) 0.97
Exaggerated object affordance and absent automatic inhibition in alien hand syndrome. Cortex (2013) 0.97
Role of the human supplementary eye field in the control of saccadic eye movements. Neuropsychologia (2006) 0.96
Slow EEG pattern predicts reduced intrinsic functional connectivity in the default mode network: an inter-subject analysis. Neuroimage (2010) 0.96
Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. NMR Biomed (2015) 0.96
Plaque hemorrhage is a marker of thromboembolic activity in patients with symptomatic carotid disease. Radiology (2010) 0.96
Human prefrontal and sensory cortical activity during divided attention tasks. Hum Brain Mapp (2003) 0.96
Cerebral perfusion in chronic stroke: implications for lesion-symptom mapping and functional MRI. Behav Neurol (2011) 0.95
Grasping premanifest Huntington's disease - shaping new endpoints for new trials. Mov Disord (2010) 0.95
Reduced cortical gray matter in narcolepsy: preliminary findings with voxel-based morphometry. Neurology (2002) 0.95
A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia. Schizophr Res (2007) 0.94
T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology (2002) 0.94
White matter T(1) relaxation time histograms and cerebral atrophy in multiple sclerosis. J Neurol Sci (2002) 0.93
Brain white matter hyperintensities are associated with carotid intraplaque hemorrhage. Radiology (2008) 0.93
Focal multiple sclerosis lesions abound in 'normal appearing white matter'. Mult Scler (2011) 0.92
Brain damage and cortical compensation in foreign accent syndrome. Neurocase (2005) 0.91
Rapid eye movement-related brain activation in human sleep: a functional magnetic resonance imaging study. Neuroreport (2005) 0.91
Improved artifact correction for combined electroencephalography/functional MRI by means of synchronization and use of vectorcardiogram recordings. J Magn Reson Imaging (2008) 0.91
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease. Brain (2014) 0.89
Diffusion-weighted magnetic resonance imaging of normal and degenerative lumbar intervertebral discs: a new method to potentially quantify the physiologic effect of physical therapy intervention. J Orthop Sports Phys Ther (2007) 0.89
Neural networks of response shifting: influence of task speed and stimulus material. Brain Res (2006) 0.89
Is sedation-induced BOLD fMRI low-frequency fluctuation increase mediated by increased motion? MAGMA (2010) 0.88
High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats. Neuroimage (2004) 0.87
Immunoreactivity to Lys63-linked polyubiquitin is a feature of neurodegeneration. Neurosci Lett (2009) 0.87
Structural white matter abnormalities in patients with idiopathic dystonia. Mov Disord (2007) 0.87
Inverse effects of oxytocin on attributing mental activity to others in depressed and healthy subjects: a double-blind placebo controlled FMRI study. Front Psychiatry (2010) 0.86
Spinal cord imaging in multiple sclerosis. J Neuroimaging (2005) 0.86
Creatine supplementation lowers brain glutamate levels in Huntington's disease. J Neurol (2005) 0.86
Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms. J Neuroimaging (2010) 0.86
Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume. Ann Neurol (2002) 0.85
A quantitative analysis of the benefits of cardiac gating in practical diffusion tensor imaging of the brain. Magn Reson Med (2010) 0.85
Magnetic resonance detected carotid plaque hemorrhage is associated with inflammatory features in symptomatic carotid plaques. Ann Vasc Surg (2013) 0.85